Analysis of premalignant pancreatic cancer mass spectrometry data for biomarker selection using a group search optimizer

Zhihua CUI, Zhongzhi SHI, Janos ABONYI, s HE, H.J. COOPER, D. WARD, x YAO, J.K. HEATH

Research output: Journal PublicationsJournal Article (refereed)peer-review

13 Citations (Scopus)

Abstract

This paper presents a novel group search optimizer (GSO)-based biomarker discovery method for pancreatic cancer diagnosis using mass spectrometry (MS) data. The GSO was inspired by animal social searching behaviour. It has been shown that the global search performance of the GSO is competitive to other biologically inspired optimization algorithms. In this study, we applied a GSO as a feature selection method to MS data analysis for premalignant pancreatic cancer biomarker discovery. We first applied a smooth non-linear energy operator to detect peaks. Then a GSO with linear discriminant analysis was used to select a parsimonious set of peak windows (biomarkers) that can distinguish cancer. After selecting a set of biomarkers, a support vector machine was then applied to build a classifier to diagnosis premalignant cancer cases. We compared the GSO algorithm with a genetic algorithm, evolution strategies, evolutionary programming and a particle swarm optimizer. The results showed that the GSO-based feature selection algorithm is capable of selecting a parsimonious set of biomarkers to achieve better classification performance than other algorithms. The source code of the proposed GSO-based feature selection algorithm is available at www.cs.bham.ac.uk/~szh. © 2011, SAGE Publications. All rights reserved.
Original languageEnglish
Pages (from-to)668-676
Number of pages9
JournalTransactions of the Institute of Measurement and Control
Volume34
Issue number6
Early online date4 Jul 2011
DOIs
Publication statusPublished - Aug 2012
Externally publishedYes

Keywords

  • Cancer biomarkers
  • feature selection
  • group search optimization
  • proteomics

Fingerprint

Dive into the research topics of 'Analysis of premalignant pancreatic cancer mass spectrometry data for biomarker selection using a group search optimizer'. Together they form a unique fingerprint.

Cite this